Latest appendicitis Stories
Study authors explain that findings published in Journal of American College of Surgeons point to the need for further research on why these racial disparities exist and what preventive interventions can be developed When researchers from UCLA Medical Center investigated the link between racial disparities and appendicitis outcomes in children, they found that the type of hospital in which black, Hispanic and other minority patients receive care—community, children's or county—affects...
Comparing favorably with other diagnostic tools The presence of pain when traveling over speed bumps is associated with an increased likelihood of acute appendicitis, among patients coming into hospital with abdominal pain, finds a study in the BMJ Christmas issue and published online today. Clinical diagnosis of acute appendicitis can be difficult and yet it is the most common surgical abdominal emergency. There is no specific clinical diagnostic test for appendicitis, and removing a...
CASTLE ROCK, Colo., Dec. 12, 2012 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), formerly AspenBio Pharma, an in vitro diagnostic company, today announced it has changed its corporate name after receiving approval from its shareholders at a Special Meeting of Shareholders held on December 11, 2012. The Company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "APPY". As part of its rebranding process Venaxis has also changed the name of the...
CASTLE ROCK, Colo., Nov. 13, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 9(th) Annual Lazard Capital Markets Healthcare Conference, held November 13-14, 2012, at the Pierre Hotel in New York City. Steve Lundy, President and CEO of AspenBio, will provide an overview of the Company's business during his live presentation and will be available to participate in one-on-one meetings with...
CASTLE ROCK, Colo.,, Nov. 6, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced it has engaged Miquel Vernet to consult with the Company as it prepares for European commercialization. Mr. Vernet will work closely with Don Hurd, Chief Commercial Officer of AspenBio. AspenBio anticipates obtaining CE Mark for its appendicitis diagnostic test before the end of the year, followed by a commercial launch in major European...
CASTLE ROCK, Colo., Nov. 5, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced it will provide a third quarter business update on Tuesday, November 13, 2012, at 4:30 p.m. ET. The conference call will be hosted by Steve Lundy, Chief Executive Officer; Jeff McGonegal, Chief Financial Officer; and Don Hurd, Senior Vice President and Chief Commercial Officer. Interested participants and investors may access the conference call by...
CASTLE ROCK, Colo., Oct. 15, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will ask its shareholders to approve changing its name to Venaxis, Inc., (pronounced: "Ven-ak'-sis"). As announced recently during the Company's clinical and business update conference call, a name change is part of a strategic rebranding of the Company in line with its focus on its blood-based appendicitis test, which is designed to assist...
Initiative promotes better visceral pain management through increased awareness SEATTLE, Oct. 15, 2012 /PRNewswire-USNewswire/ -- The Global Year Against Visceral Pain launches today, bringing global attention to pain that originates in or near the internal organs of the body. Visceral pain is the most frequent form of pain, felt by most people at one time or another, and the number one reason for patients to seek medical attention. Sponsored by the International Association for...
CASTLE ROCK, Colo., Sept. 27, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today provided its shareholders and the broader investment community with an update on its clinical and business activities. The Company announced that it plans to initiate a pivotal study in the fourth quarter of 2012 for its blood-based appendicitis test designed to assist emergency room clinicians in ruling out acute appendicitis. The Company is moving...
Lee Rannals for redOrbit.com – Your Universe Online People who are suffering from an appendicitis may not have to undergo a scalpel and sutures in the future but could instead just resort to taking some antibiotics. Typically, people suffering from an appendicitis will have to undergo surgery in order to remove their appendix. However, scientists at the Sahlgrenska Academy, University of Gothenburg, Sweden are trying to find a way around that with antibiotics. Two major clinical...
Latest appendicitis Reference Libraries
A laparoscopy is an invasive surgical procedure used in abdominal area but is much less invasive than the preceding methods. Small incisions are made in the abdomen or pelvic area in which the camera and tools are introduced to perform the surgery or inspect the area. The method before the laparoscopy involved cutting open the area completely with longer healing time and more complications. Although in the pediatric populations, abscesses have a tendency to form around the incision sites....
